Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 883-890

  Platt, Emily J ^a   Madani, Navid ^a   Kozak, Susan L ^a   Kabat, David ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; VIRUS CELL INTERACTION;

EID: 0031014643     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.883-890.1997     Document Type: Article

References (46)

1. Alizon, M., S. Wain-Hobson, L. Montagnier, and P. Sonigo. 1986. Genetic variability of the AIDS virus: nucleotidc sequence analysis of two isolates from African patients. Cell 46:63-74.
2. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
3. Aruffo, A. 1991. Transient expression of proteins using COS cells, p. 16.13.1-16.13.7. In F. M. Ausuhel et al. (ed.), Current protocols in molecular biology, John Wiley & Sons, Inc., New York, N.Y.
4. Bentz, J., H. Ellens, and D. Alford. 1993. Architecture of the influenza hemagglutinin fusion site, p. 164-199. In J. Bcntz (ed.), Viral fusion mechanisms. CRC Press, Boca Raton, Fla.
5. Chesebro, B., K. Wehrly, J. Metcalf, and D. E. Griffin. 1991. Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. J. Infect. Dis. 163:64-70.
6. Choe, H., M. Rarzan, Y. Sun, N. Sullivan, B. Rollins, L. W. Ponath, C. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HlV-1 isolates. Cell 85:1135-1148.
7. Daar, E. S., L. X. Li, T. Moudgil, and D. D. Ho. 1990. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87:6574-6578.
8. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. D. Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Liftman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
9. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusin cofactors. Cell 85:1149-1158.
10. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
11. Earl, P. L., R. W. Doms, and B. Moss. 1992. Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers. J. Virol. 66:5610-5614.
12. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
13. Fenyö, E. M., L. Morfeldt-Månson, F. Chiodi, B. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Åsjö. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
14. Fisher, A., B. Ensoli, D. Looney, A. Rose, R. C. Gallo, M. S. Saag, G. M. Shaw, B. H. Hahn, and F. Wong-Staal. 1988. Biologically diverse molecular variants within a single HIV-1 isolate. Nature 334:444-447.
15. Fujita, K., J. Silver, and K. Peden. 1992. Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1. J. Virol. 66:445-4451.
16. Graham. F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
17. Hart, T. K., R. Kirsh, H. Ellens, R. W. Sweet, D. M. Lambert, J. S. R. Petteway, J. Leary, and P. J. Bugelski. 1991. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope gp120. Proc. Natl. Acad. Sci. USA 88:2189-2193.
18. Hoxie, J. A., L. F. Brass, C. H. Pletcher, B. S. Haggarty, and B. H. Hahn. 1991. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4. J. Virol. 65:5096-5101.
19. Kabat, D., S. L. Kozak, K. Wehrly, and B. Chesebro. 1994. Differences in CD4 dependence for infection of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J. Virol. 68:2570-2577.
20. Kozak, S. L., E. J. Platt, N. Madani, F. E. Ferro, Jr., K. Peden, and D. Kabat. 1997. CD4, CXCR-4, and CCR-5 dependencies for infections hy primary patient and laboratory-adapted isolates of human immunodenciency virus type 1. J. Virol. 71:873-882.
21. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans, A. K. N. Iversen, D. Colvin, M. V. Gallo, S. Coutre, E. G. Shpaer, D. V. Faulkner, A. deRonde, S. Volkman, C. Williams, M. S. Hirsch, and J. I. Mullins. 1902. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66:875-885.
22. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, and P. L. Nara. 1990. HIV requires multiple gpl20 molecules for CD4-mediated infection. Nature 346:277-279.
23. Layne, S. P., M. J. Merges, J. L. Spouge, M. Dembo, and P. L. Nara. 1991. Blocking of human immunodenciency virus infection depends on cell density and viral stock age. J. Virol. 65:3293-3300.
24. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695-714.
25. McKeating, J. A., A. McKnight, and J. P. Moore. 1991. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J. Virol. 65:852-860.
26. Moore, J. P., J. A. McKeating, Y. Huang, A. Ashkenazi, and D. D. Ho. 1992. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66:235-243.
27. Moore, J. P., J. A. McKeating, R. A. Weiss, and Q. J. Sattentau. 1990. Dissociation of gp120 from HIV-I virions induced by soluble CD4. Science 250:1139-1142.
28. Nowak, R. 1992. Lab-bred HIV-1: is it relevant? J. NIH Res. 4:33-35.
29. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeticiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
30. Page, K. A., N. Landau, and D. R. Liftman. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
31. Platt, E. J., K. Karlsen, A. Lopez-Valdivieso, P. W. Cook, and G. L. Firestone. 1986. Highly sensitive immunoadsorption procedure for detection of low-abundance proteins. Anal. Biochem. 156:126-135.
32. Rey, E. A., F. X. Heinz, C. Mandi, C. Kunz, and S. C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291-298.
33. Rieber, E. P., C. Federle, C. Reiter. S. Krauss, L. Gurtler, J. Eberle, F. Denhardt, and G. Riethmuller. 1992. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure pro-phylaxis. Proe. Natl. Acad. Sci. USA 89:10792-10796.
34. Sakai, K., S. Dewhurst, X. Ma, and D. J. Volsky. 1988. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J. Virol. 62:4078-4085.
35. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodenciency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
36. Sattentau, Q. J., J. P. Moore, E. Vignaux, F. Traincard, and P. Poignard. 1993. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67:7383-7393.
37. Siess, D. C-, S. L. Kozak, and D. Kabat. 1996. Exceptional fusogenicily of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process. J. Virol. 70:3432-3439.
38. Stegman, T., and A. Helenius. 1993. Influenza virus fusion: from models toward a mechanism, p. 90-106. In J. Benlz (ed.). Viral fusion mechanisms. CRC Press, Boca Raton, Fla.
39. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replieative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
40. Tersmette, M., R. E. Y. de Goede, B. J. M. Al, I. N. Winkel, R. A. Gruters, H. T. Cuypers, H. G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodenciency syndrome (AIDS) and AIDS-relaled complex. J. Virol. 62:2026-2032.
41. Thali, M., U. Olshevsky, C. Furman, D. Gabuzda, J. Li, and J. Sodroski. 1991. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity. J. Virol. 65:5007-5012.
42. Turner, S., R. Tizard, J. DeMarinis, R. B. Pepinsky, J. Zullo, R. Schooley, and R. Fisher. 1992. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89:1335-1339.
43. Wang, H., R. Paul, R. E. Burgeson, D. R. Keene, and D. Kabat. 1991. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J. Virol. 65:6468-6477.
44. White, J. M. 1994. Fusion of influenza virus in endosomes: role of the hemagglutinin, p. 281-301. In E. Wimmer (ed.), Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
45. Willey, R. L., M. A. Martin, and K. W. C. Peden. 1994. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1. J. Virol. 68:1029-1039.
46. Wrin, T., T. P. Loh, J. C. Vennari, H. Schuitemaker, and J. H. Nunberg. 1995. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:39-48.